Literature DB >> 11865883

No-suicide contracts: an overview and recommendations.

Lillian M Range1, Catherine Campbell, Stacey H Kovac, Michelle Marion-Jones, Holly Aldridge, Stephen Kogos, Yolanda Crump.   

Abstract

No-suicide contracts, in their various forms, can deepen commitment to a positive action, strengthen the therapeutic alliance, facilitate communication, lower anxiety, aid assessment, and document precautions. Conversely, they can anger or inhibit the client, introduce coercion into therapy, be used disingenuously, and induce false security in the clinician. Research on no-suicide contracts (frequency surveys, assessments of behavior after contracting, and opinions of users) has limitations common to naturalistic studies, and is now ready for more rigorous methods. Mental health professions should be trained to deal with suicidal individuals, including how to use no-suicide contracts. Good contracts are specific, individualized, collaborative, positive, context-sensitive, and copied. However, they are not a thorough assessment, a guarantee against legal liability, nor a substitute for a caring, sensitive therapeutic interaction. No-suicide contracts are no substitute for sound clinical judgment.

Entities:  

Mesh:

Year:  2002        PMID: 11865883     DOI: 10.1080/07481180210147

Source DB:  PubMed          Journal:  Death Stud        ISSN: 0748-1187


  3 in total

1.  Assessing Variability and Implementation Fidelity of Suicide Prevention Safety Planning in a Regional VA Healthcare System.

Authors:  Jennifer M Gamarra; Matthew T Luciano; Jaimie L Gradus; Shannon Wiltsey Stirman
Journal:  Crisis       Date:  2015

Review 2.  A multidisciplinary approach to therapeutic risk management of the suicidal patient.

Authors:  Cynthia L Grant; Jaimie L Lusk
Journal:  J Multidiscip Healthc       Date:  2015-06-24

3.  Health Professionals Facing Suicidal Patients: What Are Their Clinical Practices?

Authors:  Inês Rothes; Margarida Henriques
Journal:  Int J Environ Res Public Health       Date:  2018-06-08       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.